3 Cancer Treatment Stocks to Buy Right Now
These three beaten-down cancer stocks could prove to be amazing value plays.
Agenus
AGEN
AGEN
$2.62
-$0.06
-2.2%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive AGEN Charts
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
News & Analysis: Agenus
The Fool has written over 100 articles on Agenus.
Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2019.
Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2019.
3 Top Growth Stocks to Buy Right Now
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers.
Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript
AGEN earnings call for the period ending December 31, 2018.
The 3 Oldest Members of Biotech's Billion-Burned Club
These biopharmaceutical startups have been losing their investors' money for decades.
Why Agenus Inc. Stock Took Flight in January
Agenus' stock crushed it last month. Here's why.
Why Agenus Stock Is Spiking Today
Eli Lilly's acquisition of Loxo Oncology lit a fire underneath the cancer immunotherapy company today.
All the Pre-JPM News Healthcare Investors Need to Know
The Super Bowl of biotech kicked off early for these companies.
Why Celgene, Agenus, and Incyte Jumped Today
Biotech was a popular sector today. Find out why.
